{Reference Type}: Journal Article {Title}: Implementation of a centralized, web-based surveillance for healthcare associated infections among residents of long-term care facilities in Italy. {Author}: Vicentini C;Russotto A;Bazzolo S;Rolfini E;Blengini V;Gamba D;Agodi A;Barchitta M;Bellio S;Fabbri E;Forni S;Ricchizzi E;Ripabelli G;Sticchi C;D'Ancona FP;Zotti CM; ; {Journal}: Public Health Pract (Oxf) {Volume}: 6 {Issue}: 0 {Year}: 2023 Dec 暂无{DOI}: 10.1016/j.puhip.2023.100421 {Abstract}: UNASSIGNED: The Italian National Action Plan to contrast AMR identified among its objectives the development and implementation of a national Healthcare-Associated Infection (HAI) surveillance system based on European Centre for Disease Prevention and Control (ECDC) indications, through point prevalence surveys (PPS) of HAIs and antibiotic use in acute-care hospitals and long-term care facilities (LTCFs). We aimed to assess feasibility and appropriateness of proposed tools for a national surveillance system of HAIs and antibiotic use in LTCFs.
UNASSIGNED: Point prevalence survey.
UNASSIGNED: A pilot PPS was conducted between May-June 2022, among 15 LTCFs of 7 Italian regions. Data were collected in a single day in each LTCF, at the LTCF, ward, and resident levels, using a web-based data collection tool developed ad hoc. Data collector teams of each facility were invited to complete a questionnaire investigating opinions on the proposed tools.
UNASSIGNED: Among 1025 included residents, the prevalence of residents with at least one HAI was 2.5% (95% CI 1.7%-3.7%) considering all HAIs and 2.2% (95% CI 1.3%-3%) without considering SARS-CoV-2 infections. The prevalence of antimicrobial use was 3% (95% CI 0.2%-4.3%). Overall, most respondents were satisfied with the web-based software, training and protocol, even though some difficulties were reported.
UNASSIGNED: A national surveillance network was established, which will facilitate future surveillance efforts. Further studies are necessary to evaluate the impact of the pandemic on HAI transmission and antibiotic use in LTCFs.